RIPK3 and Duchenne muscular dystrophy: In Duchenne muscular dystrophy (DMD), genetic ablation of Ripk3 in mdx mice significantly reduced myofibre degeneration, inflammation, and fibrosis, leading to improved muscle function, establishing RIPK3 as a key degenerative mediator (Morgan et al., 2018b).